SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Gilead Science (GILD) Followers
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
961 87 0 GILD
Emcee:  SybilNicolas Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
611 It's the "biotech stocks go down in summer" crowd. Pick stocks tscaram(o)uche-4/19/1999
610 Whooooo!!!!! What happened today??? Down over 4 bucks on heavy volume. Good Steve Johnston-4/19/1999
609 I don't think it says anything at all about the relative benefit of placebobiodoc-4/12/1999
608 No, not a word. Also, didn't read PDLI 10K file , so do not know what is gMiljenko Zuanic-4/12/1999
607 OK, got you. Wish I shared your enthusiasm for Preveon. I still hurt from thescaram(o)uche-4/11/1999
606 Rick, That is exactly my point. NO difference! However, what I want to said iMiljenko Zuanic-4/11/1999
605 MZ: I'm certain that you will agree that 4/42 is not different than 7/99. scaram(o)uche-4/11/1999
604 BCHE's Lamivudine results for HBV: biz.yahoo.com <<An analysis of thMiljenko Zuanic-4/11/1999
603 What really happened today? The market sold off in response to a couple of dowToby Zidle-3/22/1999
602 Explain that to *expert* analyst at ML! Miljenko Miljenko Zuanic-3/22/1999
601 Oh yeah, In that estimate I gave Gilead all of the 4104 sales. OOps. The BradleyMarshall-3/22/1999
600 Today's news brings up valuation issues..... so let's do the math. To BradleyMarshall-3/22/1999
599 I think I've seen you post in the nxtr category. I'm in the same camp Chris Boylan-3/9/1999
598 The cocktail approach has been quite successful. However, resistance does showRob-Chemist-3/9/1999
597 from Rob-Chemist > While I have no doubt that simultaneous resistance to PChris Boylan-3/9/1999
596 A drug that has a single daily dose has a tremendous advantage over an equally Rob-Chemist-3/9/1999
595 Anyone have a comment on the following? thestreet.com I haven't been follChris Boylan-3/8/1999
594 Gilead Shares Soar to Record on HIV Drug Trial Data (Update1) Bloomberg Anthony Wong-3/4/1999
593 More on Prudential's recommendation: GILEAD SCIENCES Prudential reiterateAnthony Wong-3/4/1999
592 Gilead Sciences Reiterated 'Strong Buy' at Prudential Bloomberg Anthony Wong-3/4/1999
591 Gilead HIV Drug Safer, Effective at Lower Dose, Study news.comAnthony Wong-3/4/1999
590 Is anyone noticing the sudden surge in volume and price today? I suspect we areAJAG-3/4/1999
589 GILD DLJ reiterates marketperform, raised 1999 estimates & target to $45 GIAnthony Wong-2/25/1999
588 Prudential reitierated its strong buy rating today, target 56, best idea, and MAJAG-2/25/1999
587 Glaxo's Relenza Flu Drug Rejected by U.S. FDA Panel (Update10) BloomAnthony Wong-2/24/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News